Image depicting research in biotechnology and health sciences getty

China’s biotech sector is surging. For the first time, it now leads the world in clinical trials and new drug licensing. The U.S., once the undisputed leader in pharmaceutical innovation, risks losing its competitive edge unless decisive action is taken.

To safeguard both our economy and national security, the U.S. must make biotechnology a strategic priority: rebuilding domestic capacity, aligning incentives and fostering an environment where innovation can thrive on American soil.

Pharmaceutical innovation is one of America’s crown jewels. The industry has long been an engine of global competitiveness and public health. For decades, our ecosystem of universities, capital markets and entrepreneurial risk-taking mad

See Full Page